Loading people...
Katie Rodan is an Angel Investor at Broadway Angels and the Co-Founder of Rodan + Fields, based in Oakland, California. Alongside Dr. Kathy Fields, she co-created the acne treatment Proactiv in 1995, which later resulted in a $50 million buyout for her royalty rights. The duo subsequently launched Rodan + Fields in 2002, selling the brand to Estée Lauder in 2003 before buying it back in 2007 and scaling it to $1.15 billion in net revenue by 2016, later securing a minority investment from TPG Capital. She earned her medical degree from the University of Southern California and completed her dermatology residency at Stanford University, where she serves as an Adjunct Clinical Assistant Professor. Her current focus centers on angel investing in early-stage information technology and consumer startups, particularly supporting female-led enterprises through Broadway Angels.
Katie Rodan stands out as a prominent angel investor and a valued member of Broadway Angels, an esteemed group of leading women investors. Her journey into the investment world is underpinned by an extraordinary career as a dermatologist and a highly successful entrepreneur. Rodan is best known as the co-founder of Rodan + Fields, a revolutionary skincare brand that has achieved immense success through its direct-to-consumer model. Prior to this, she also co-created Proactiv Solution, another iconic brand that transformed the acne treatment market.
This profound background in building and scaling multi-million dollar consumer brands provides Katie Rodan with unparalleled insight into market trends, product development, and effective go-to-market strategies. As an angel investor, she leverages this expertise to identify and nurture promising early-stage companies. Her investment focus areas naturally gravitate towards sectors where she possesses deep domain knowledge, including consumer goods, health and wellness, beauty technology, and direct-to-consumer businesses. She is particularly interested in innovative solutions that address genuine consumer needs and have the potential for significant market disruption.
At Broadway Angels, Katie Rodan contributes to a collective mission of empowering the next generation of entrepreneurs, often with a specific emphasis on supporting women-led ventures and diverse founding teams. Her involvement extends beyond capital provision; she acts as a strategic advisor, offering invaluable guidance on brand building, marketing, distribution, and scaling operations. Companies fortunate enough to receive investment from Rodan benefit not only from her financial backing but also from her mentorship and extensive network within the consumer and healthcare industries.
Her career trajectory exemplifies a rare blend of medical expertise, entrepreneurial vision, and investment acumen. From her beginnings as a practicing dermatologist to co-founding two of the most successful skincare brands globally, and now as an influential angel investor, Katie Rodan consistently demonstrates a keen eye for innovation and a commitment to fostering growth. Her contributions to the startup ecosystem, particularly in the consumer and health tech spaces, continue to shape the landscape for emerging businesses seeking experienced guidance and strategic capital.
Katie Rodan is a distinguished dermatologist, entrepreneur, and angel investor. She is widely recognized as the co-founder of the highly successful skincare brands Rodan + Fields and Proactiv Solution, and is an active member of Broadway Angels.
Katie Rodan primarily invests in early-stage companies, focusing on sectors where she has deep expertise. These include consumer goods, health and wellness, beauty technology, and direct-to-consumer businesses. She often supports innovative solutions and diverse founding teams.
Katie Rodan is an angel investor and a member of Broadway Angels, an esteemed group of women investors. Her work involves identifying, investing in, and advising promising startups, leveraging her extensive entrepreneurial background.
